Back to Search Start Over

Comparison of 90-day complication rates and readmissions of primary total elbow arthroplasty in elective and traumatic cases: a single center experience.

Authors :
Gambhir, Neil
Alben, Matthew G.
Shankar, Dhruv
Larose, Gabriel
Kwon, Young W.
Virk, Mandeep S.
Source :
European Journal of Orthopaedic Surgery & Traumatology. Aug2023, Vol. 33 Issue 6, p2303-2308. 6p.
Publication Year :
2023

Abstract

Introduction: The purpose of this study is to compare the 90 day complication rates of primary Total Elbow Arthroplasty (TEA) performed for arthritis (primary-OA; rheumatoid arthritis-RA) versus those performed for distal humerus fractures (DHF). Methods: Patients who underwent a TEA from 2015 to 2021 were identified from our institutional database and placed into cohorts based on surgical indications (TEA-OA, TEA-RA and TEA-DHF). Chart review was conducted to analyze the prevalence of complications, emergency department (ED) visits, readmissions, and secondary procedures in the first 90 day post-operative period. Complications included but were not limited to wound complications, hematoma, infection (superficial or deep), nerve palsy, periprosthetic fracture/failure and others. Results: 49 patients who underwent TEA were included in this study: (DHF = 19, OA = 14, RA = 16). Six complications occurred within the first 90 days of surgery. There were two periprosthetic joint infections (PJI) in the OA group, requiring irrigation and debridement (I & D) within the first 90 days of surgery. There were three post-operative ulnar nerve palsies and one PJI requiring I & D in the TEA-RA group. Compared to the TEA-DHF and TEA-OA groups, the RA group had higher rates of all-cause complications (p = 0.03) and nerve palsy (p = 0.03). There were no significant differences between groups in readmissions (p = 0.27) or secondary interventions (p = 0.27). Conclusion: The 90-day complication/readmission rates of TEA preformed for DHFs is lower than those preformed for OA and RA. These differences could be related to the underlying chronic inflammatory etiology and side effect of treatments (intraarticular steroid injection, and biologics) received by patients with arthritis. Level of Evidence: Retrospective Cohort Study, level IV. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
16338065
Volume :
33
Issue :
6
Database :
Academic Search Index
Journal :
European Journal of Orthopaedic Surgery & Traumatology
Publication Type :
Academic Journal
Accession number :
166735789
Full Text :
https://doi.org/10.1007/s00590-022-03425-6